Comparison

Anhydroerythromycin A European Partner

€377.00
Excl. VAT
Item no. HY-N7454-1mg
Manufacturer MedChem Express
CASRN 23893-13-2
Amount 1 mg
Category
Type Inhibitors
Specific against other
Formula C37H65NO12
Citations [1]Sunazuka T, et al. Effects of erythromycin and its derivatives on interleukin-8 release by human bronchial epithelial cell line BEAS-2B cells. J Antibiot (Tokyo). 1999 Jan;52(1):71-4.
Smiles C[C@H]([C@H]1O)[C@@](O[C@@]1([C@H](OC2=O)CC)C)([C@@H](C3)C)O[C@]3([C@@H]([C@H]([C@@H]([C@H]2C)O[C@H](O[C@H]4C)C[C@](C)([C@H]4O)OC)C)O[C@H](O[C@@H]5C)[C@@H]([C@H](C5)N(C)C)O)C
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Product Description
Anhydroerythromycin A is a degradation product of the macrolide antibiotic erythromycin. Anhydroerythromycin A is formed via degradation of erythromycin in acidic aqueous solutions in vitro as well as in vivo. Anhydroerythromycin A is active against S. aureus and B. cereus in vitro (MICs = 12.5 and 6.25 μg/ml, respectively). Anhydroerythromycin A also inhibits steroid 6β-hydroxylase activity associated with the cytochrome P450 (CYP) isoform CYP3A in human liver microsomes.
Shipping
Room temperature
Molecular Weight
715.91
Clinical Information
Launched
Solubility
10 mM in DMSO
Isoform
Macrolide
Pathway
Anti-infection
Manufacturers Product type
Natural Products

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
Listprice: €377.00
Price: €377.00
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close